Susquehanna Portfolio Strategies »

Amicus Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.5M 1.1M 7.88
2025-06-30 $7.2M 1.3M 5.73

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics